ABEO
Abeona Therapeutics Inc.$5.38+0.04 (+0.84%)Prev Close$5.34·MCap$304.6M·P/E5.25·Vol270.4K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
36
$4.34M
◆
Net Activity
Net Seller
$4.34M
●
Active Insiders
10
last 12 mo
Over the past 12 months, insider activity at Abeona Therapeutics Inc. (ABEO) has been exclusively selling, with 0 insider purchases totaling $0.00 and 36 insider sales totaling $4.34M. The most recent insider transaction was by Seshadri Vishwas (director, officer: Chief Executive Officer), who sold $131.5K worth of shares on Mar 31, 2026. Abeona Therapeutics Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $304.6M.
ABEO Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | Seshadri Vishwas | director, officer: Chief Executive Officer | Sell | 29,985 | $4.38 | $131.5K | 1,430,423 |
| Mar 16, 2026 | Vazzano Joseph Walter | officer: Chief Financial Officer | Sell | 785 | $4.76 | $3.7K | 567,775 |
| Feb 4, 2026 | Silverstein Christine Berni | director | Sell | 20,070 | $5.09 | $102.2K | 137,722 |
| Feb 2, 2026 | Alland Leila | Director | Sell | 36,130 | $5.09 | $183.9K | 173,614 |
| Feb 2, 2026 | Alvino Mark | Director | Sell | 4,000 | $5.09 | $20.4K | 84,065 |
| Feb 2, 2026 | Crombez Eric | Director | Sell | 32,568 | $5.09 | $165.8K | 63,456-34% |
| Feb 2, 2026 | Wuchterl Donald A. | Director | Sell | 29,628 | $5.09 | $150.8K | 167,935 |
| Feb 2, 2026 | Silverstein Christine Berni | Director | Sell | 20,070 | $5.09 | $102.2K | 0 |
| Jan 26, 2026 | Vasanthavada Madhav | officer: Chief Commercial Officer | Sell | 12,610 | $5.29 | $66.7K | 318,619 |
| Jan 22, 2026 | O'Malley Brendan M. | SVP, Chief Legal Officer | Sell | 27,156 | $5.33 | $144.8K | 451,134 |
| Jan 22, 2026 | Seshadri Vishwas | director, officer: Chief Executive Officer | Sell | 139,664 | $5.33 | $744.5K | 1,460,408 |
| Jan 22, 2026 | Vazzano Joseph Walter | officer: Chief Financial Officer | Sell | 37,332 | $5.33 | $199.0K | 568,560 |
| Jan 21, 2026 | Alvino Mark | Director | Sell | 27,000 | $5.23 | $141.1K | 48,752-36% |
| Jan 20, 2026 | Vasanthavada Madhav | Chief Commercial Officer | Sell | 12,610 | $5.29 | $66.7K | 0 |
| Dec 29, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 25,000 | $5.31 | $132.7K | 0 |
| Nov 13, 2025 | Alvino Mark | Director | Sell | 15,000 | $4.74 | $71.2K | 0 |
| Oct 16, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 249 | $5.49 | $1.4K | 0 |
| Sep 29, 2025 | O'Malley Brendan M. | SVP, Chief Legal Officer | Sell | 9,366 | $5.39 | $50.5K | 0 |
| Sep 29, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 44,274 | $5.31 | $234.9K | 0 |
| Sep 29, 2025 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 9,035 | $5.39 | $48.7K | 0 |
| Sep 22, 2025 | O'Malley Brendan M. | SVP, Chief Legal Officer | Sell | 688 | $5.43 | $3.7K | 0 |
| Aug 15, 2025 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 15,000 | $7.36 | $110.4K | 0 |
| Aug 14, 2025 | Crombez Eric | Director | Sell | 4,718 | $6.93 | $32.7K | 0 |
| Jul 22, 2025 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 1,502 | $6.64 | $10.0K | 0 |
| Jul 9, 2025 | Charles Faith L. | Director | Sell | 10,738 | $5.86 | $62.9K | 0 |
| Jul 9, 2025 | O'Malley Brendan M. | SVP, Chief Legal Officer | Sell | 17,428 | $5.86 | $102.1K | 0 |
| Jul 9, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 69,420 | $5.86 | $406.5K | 0 |
| Jul 9, 2025 | Silverstein Christine Berni | Director | Sell | 13,093 | $5.86 | $76.7K | 0 |
| Jul 9, 2025 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 25,411 | $5.86 | $148.8K | 0 |
| Jul 8, 2025 | Wuchterl Donald A. | Director | Sell | 5,176 | $5.82 | $30.1K | 0 |
| Jun 6, 2025 | O'Malley Brendan M. | SVP, General Counsel | Sell | 10,470 | $6.76 | $70.8K | 0 |
| Jun 6, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 50,676 | $6.76 | $342.6K | 0 |
| Jun 6, 2025 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 17,795 | $6.76 | $120.3K | 0 |
| Jun 1, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 885 | $6.24 | $5.5K | 0 |
| May 27, 2025 | Alvino Mark | Director | Sell | 2,000 | $6.38 | $12.8K | 0 |
| May 16, 2025 | Alvino Mark | Director | Sell | 8,000 | $5.68 | $45.4K | 0 |
| Mar 31, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 25,000 | $4.78 | $119.5K | 0 |
| Mar 14, 2025 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 685 | $5.29 | $3.6K | 0 |
| Mar 3, 2025 | O'Malley Brendan M. | SVP, General Counsel | Sell | 181 | $5.24 | $948.44 | 0 |
| Jan 29, 2025 | Alvino Mark | Director | Sell | 4,000 | $5.38 | $21.5K | 0 |
| Jan 21, 2025 | Alvino Mark | Director | Sell | 4,000 | $5.10 | $20.4K | 0 |
| Oct 16, 2024 | Seshadri Vishwas | Chief Executive Officer | Sell | 251 | $6.54 | $1.6K | 0 |
| Sep 28, 2024 | O'Malley Brendan M. | SVP, General Counsel | Sell | 6,579 | $5.89 | $38.8K | 0 |
| Sep 28, 2024 | Seshadri Vishwas | Chief Executive Officer | Sell | 18,798 | $5.89 | $110.7K | 0 |
| Sep 28, 2024 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 6,388 | $5.89 | $37.6K | 0 |
| Sep 20, 2024 | O'Malley Brendan M. | SVP, General Counsel | Sell | 496 | $6.02 | $3.0K | 0 |
| Jul 21, 2024 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 1,055 | $5.11 | $5.4K | 0 |
| Jun 17, 2024 | Alvino Mark | Director | Sell | 25,890 | $4.51 | $116.8K | 0 |
| Jun 17, 2024 | Silverstein Christine Berni | Director | Sell | 25,821 | $4.51 | $116.5K | 0 |
| Jun 5, 2024 | O'Malley Brendan M. | SVP, General Counsel | Sell | 10,951 | $4.52 | $49.5K | 0 |
Showing 1–50 of 105
1 / 3
ABEO Insider Buying Activity
The following table shows recent insider purchases of Abeona Therapeutics Inc. (ABEO) stock reported via SEC Form 4 filings.
No insider buying activity found for ABEO in the last 12 months.
ABEO Insider Selling Activity
The following table shows recent insider sales of Abeona Therapeutics Inc. (ABEO) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | Seshadri Vishwas | director, officer: Chief Executive Officer | Sell | 29,985 | $4.38 | $131.5K | 1,430,423 |
| Mar 16, 2026 | Vazzano Joseph Walter | officer: Chief Financial Officer | Sell | 785 | $4.76 | $3.7K | 567,775 |
| Feb 4, 2026 | Silverstein Christine Berni | director | Sell | 20,070 | $5.09 | $102.2K | 137,722 |
| Feb 2, 2026 | Alland Leila | Director | Sell | 36,130 | $5.09 | $183.9K | 173,614 |
| Feb 2, 2026 | Alvino Mark | Director | Sell | 4,000 | $5.09 | $20.4K | 84,065 |
| Feb 2, 2026 | Crombez Eric | Director | Sell | 32,568 | $5.09 | $165.8K | 63,456-34% |
| Feb 2, 2026 | Wuchterl Donald A. | Director | Sell | 29,628 | $5.09 | $150.8K | 167,935 |
| Feb 2, 2026 | Silverstein Christine Berni | Director | Sell | 20,070 | $5.09 | $102.2K | 0 |
| Jan 26, 2026 | Vasanthavada Madhav | officer: Chief Commercial Officer | Sell | 12,610 | $5.29 | $66.7K | 318,619 |
| Jan 22, 2026 | O'Malley Brendan M. | SVP, Chief Legal Officer | Sell | 27,156 | $5.33 | $144.8K | 451,134 |
| Jan 22, 2026 | Seshadri Vishwas | director, officer: Chief Executive Officer | Sell | 139,664 | $5.33 | $744.5K | 1,460,408 |
| Jan 22, 2026 | Vazzano Joseph Walter | officer: Chief Financial Officer | Sell | 37,332 | $5.33 | $199.0K | 568,560 |
| Jan 21, 2026 | Alvino Mark | Director | Sell | 27,000 | $5.23 | $141.1K | 48,752-36% |
| Jan 20, 2026 | Vasanthavada Madhav | Chief Commercial Officer | Sell | 12,610 | $5.29 | $66.7K | 0 |
| Dec 29, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 25,000 | $5.31 | $132.7K | 0 |
| Nov 13, 2025 | Alvino Mark | Director | Sell | 15,000 | $4.74 | $71.2K | 0 |
| Oct 16, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 249 | $5.49 | $1.4K | 0 |
| Sep 29, 2025 | O'Malley Brendan M. | SVP, Chief Legal Officer | Sell | 9,366 | $5.39 | $50.5K | 0 |
| Sep 29, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 44,274 | $5.31 | $234.9K | 0 |
| Sep 29, 2025 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 9,035 | $5.39 | $48.7K | 0 |
| Sep 22, 2025 | O'Malley Brendan M. | SVP, Chief Legal Officer | Sell | 688 | $5.43 | $3.7K | 0 |
| Aug 15, 2025 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 15,000 | $7.36 | $110.4K | 0 |
| Aug 14, 2025 | Crombez Eric | Director | Sell | 4,718 | $6.93 | $32.7K | 0 |
| Jul 22, 2025 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 1,502 | $6.64 | $10.0K | 0 |
| Jul 9, 2025 | Charles Faith L. | Director | Sell | 10,738 | $5.86 | $62.9K | 0 |
| Jul 9, 2025 | O'Malley Brendan M. | SVP, Chief Legal Officer | Sell | 17,428 | $5.86 | $102.1K | 0 |
| Jul 9, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 69,420 | $5.86 | $406.5K | 0 |
| Jul 9, 2025 | Silverstein Christine Berni | Director | Sell | 13,093 | $5.86 | $76.7K | 0 |
| Jul 9, 2025 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 25,411 | $5.86 | $148.8K | 0 |
| Jul 8, 2025 | Wuchterl Donald A. | Director | Sell | 5,176 | $5.82 | $30.1K | 0 |
| Jun 6, 2025 | O'Malley Brendan M. | SVP, General Counsel | Sell | 10,470 | $6.76 | $70.8K | 0 |
| Jun 6, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 50,676 | $6.76 | $342.6K | 0 |
| Jun 6, 2025 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 17,795 | $6.76 | $120.3K | 0 |
| Jun 1, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 885 | $6.24 | $5.5K | 0 |
| May 27, 2025 | Alvino Mark | Director | Sell | 2,000 | $6.38 | $12.8K | 0 |
| May 16, 2025 | Alvino Mark | Director | Sell | 8,000 | $5.68 | $45.4K | 0 |
| Mar 31, 2025 | Seshadri Vishwas | Chief Executive Officer | Sell | 25,000 | $4.78 | $119.5K | 0 |
| Mar 14, 2025 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 685 | $5.29 | $3.6K | 0 |
| Mar 3, 2025 | O'Malley Brendan M. | SVP, General Counsel | Sell | 181 | $5.24 | $948.44 | 0 |
| Jan 29, 2025 | Alvino Mark | Director | Sell | 4,000 | $5.38 | $21.5K | 0 |
| Jan 21, 2025 | Alvino Mark | Director | Sell | 4,000 | $5.10 | $20.4K | 0 |
| Oct 16, 2024 | Seshadri Vishwas | Chief Executive Officer | Sell | 251 | $6.54 | $1.6K | 0 |
| Sep 28, 2024 | O'Malley Brendan M. | SVP, General Counsel | Sell | 6,579 | $5.89 | $38.8K | 0 |
| Sep 28, 2024 | Seshadri Vishwas | Chief Executive Officer | Sell | 18,798 | $5.89 | $110.7K | 0 |
| Sep 28, 2024 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 6,388 | $5.89 | $37.6K | 0 |
| Sep 20, 2024 | O'Malley Brendan M. | SVP, General Counsel | Sell | 496 | $6.02 | $3.0K | 0 |
| Jul 21, 2024 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 1,055 | $5.11 | $5.4K | 0 |
| Jun 17, 2024 | Alvino Mark | Director | Sell | 25,890 | $4.51 | $116.8K | 0 |
| Jun 17, 2024 | Silverstein Christine Berni | Director | Sell | 25,821 | $4.51 | $116.5K | 0 |
| Jun 5, 2024 | O'Malley Brendan M. | SVP, General Counsel | Sell | 10,951 | $4.52 | $49.5K | 0 |
ABEO Insiders
Seshadri Vishwas
director, officer: Chief Executive Officer
Bought $201.2KSold $2.48M
21 tradesLast: Mar 31, 2026
Vazzano Joseph Walter
officer: Chief Financial Officer
Bought $39.1KSold $798.4K
18 tradesLast: Mar 16, 2026
Similar Stocks to ABEO
VRTX
Vertex Pharmaceuticals Incorporated
$429.47+0.81%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$734.06-1.39%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$303.44-1.64%
$41.24B
INSM
Insmed Incorporated
$135.11-0.64%
$30.79B
RVMD
Revolution Medicines, Inc.
$144.62+9.92%
$29.51B
UTHR
United Therapeutics Corporation
$566.69+0.03%
$25.13B
MRNA
Moderna, Inc.
$47.16-3.17%
$21.42B
RPRX
Royalty Pharma plc
$49.40-0.50%
$21.20B